RhoGDIα suppresses growth and survival of prostate cancer cells

BACKGROUND: Treatment for primary prostate cancer (CaP) is the withdrawal of androgens. However, CaP eventually progresses to grow in a castration-resistant state. The mechanisms involved in the development and progression of castration-resistant prostate cancer (CRPC) remain unknown. We have previo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Zhu, Yezi, Tummala, Ramakumar, Liu, Chengfei, Nadiminty, Nagalakshmi, Lou, Wei, Evans, Christopher P., Zhou, Qinghua, Gao, Allen C.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961824/
https://ncbi.nlm.nih.gov/pubmed/21681778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21441
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы